Transdermal administration of an enalapril ester

Details for Australian Patent Application No. 2002332544 (hide)

Owner NOVEN PHARMACEUTICALS, INC.

Inventors Nguyen, Viet; Li, Chensheng

Agent Davies Collison Cave

Pub. Number AU-A-2002332544

PCT Number PCT/US02/25981

PCT Pub. Number WO2003/022270

Priority 60/318,632 13.09.01 US; 10/014,785 14.12.01 US

Filing date 13 September 2002

Wipo publication date 24 March 2003

International Classifications

A61K 031/40 - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 009/70 Medicinal preparations characterised by special physical form - Web, sheet or filament bases

A61P 009/04 Drugs for disorders of the cardiovascular system

A61P 009/10 Drugs for disorders of the cardiovascular system

A61P 009/12 Drugs for disorders of the cardiovascular system

A61P 013/12 Drugs for disorders of the urinary system

Event Publications

13 February 2003 Complete Application Filed

  Priority application(s): 60/318,632 13.09.01 US; 10/014,785 14.12.01 US

19 June 2003 Application Open to Public Inspection

  Published as AU-A-2002332544

23 March 2006 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002332545-INTERFACE MODULE FOR A CONTROLLED COMPONENT

2002332543-NOVEL SECRETED PROTEINS AND THEIR USES